US 7,030,108 B2Granted

Combating Parkinson's disease-related movement disorder

AssigneesReed Richter, Steven J. Hultquist

InventorsVirginia Pact Richter, Thomas Giduz

Life of this patent

Estimating the term…

Abstract

A method of combating movement disorder is disclosed in a patient with Parkinson's disease comprising administering an effective amount of mirtazapine, a receptor antagonist for 5HT2/3 and α2 receptors.

Claims14

Dependent claims

A method of combating Parkinson's disease-related movement disorder in a patient experiencing or susceptible to same who is being treated with dopaminergic medication, anticonvulsant medication or antianxiolytic medication, said method comprising administering to the patient an effective amount of mirtazapine.

Dependencies are inferred from the claim text.

Facts

Application: 09/940,309Filed 27 Aug 2001 · continuation
Priority: 15 Sep 1999
Published: US 2002/0035057 A121 Mar 2002
Granted: 18 Apr 2006
Term ends: Not estimatedThe source records don’t support an estimate.

Classification6 codes

A61K 31/00
Medicinal preparations containing organic active ingredients
A61K 31/55
Having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins: having seven-membered rings, e.g. azelastine, pentylenetetrazole
A61P 25/14
Drugs for disorders of the nervous system: for treating abnormal movements, e.g. chorea, dyskinesia
A61P 25/16
For treating abnormal movements, e.g. chorea, dyskinesia: anti-Parkinson drugs

Family

Application09/396,335Parent of this continuation · filed 15 Sep 1999
US 6,281,207 B1Parent of this continuation · filed 28 Aug 2001
US 2002/0035057 A1Pre-grant publication · published 21 Mar 2002
US 7,030,108 B2This patent

From the US filing history. Foreign family members aren’t listed.

Timeline

Citations

Open elsewhere

patentgrep

Loading patent…

patentgrepSearch patents

Back to results